Vermillion Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-27
Closed -$1.7K 1802
2026
Q1
$1.7K Buy
+27
New +$1.88K ﹤0.01% 693
2025
Q4
Sell
-29
Closed -$1.95K 648
2025
Q3
$1.95K Buy
+29
New +$2.29K ﹤0.01% 1400

Other funds holding DXCM

Vermillion Wealth Management's DXCM Position: Q2 2026 in Review

Vermillion Wealth Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 27 shares — an estimated $1.7K sold.

Vermillion Wealth Management first reported a position in DXCM in Q3 2025 and held it in 2 quarters. The position peaked at $1.95K in Q3 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Vermillion Wealth Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Vermillion Wealth Management sold 27 DexCom shares in Q2 2026, an estimated $1.7K.
  • Vermillion Wealth Management first reported a position in DexCom in Q3 2025 and held it in 2 quarters.
  • Vermillion Wealth Management's DexCom position peaked at $1.95K in Q3 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.